Management of childhood constipation

G Clayden1, A S Keshtgar

  • 1Guy's, King's, St Thomas' School of Medicine, Paediatrics, St Thomas' Hospital, London, UK. graham.clayden@kcl.ac.uk

Insights

Childhood constipation involves physical and psychological factors, creating difficult cycles of stool retention and pain. Effective management requires understanding these interactions and employing medical, psychological, and surgical strategies.

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychology

Background:

  • Childhood constipation often stems from a cycle of physical pain and psychological fear, leading to defecation avoidance.
  • This avoidance results in increased fecal retention, rectal distension, and the repeated passage of hard stools.
  • Overflow incontinence exacerbates the problem, causing significant distress in older children.

Purpose of the Study:

  • To review the interplay of physical and psychological factors in childhood constipation.
  • To outline current medical, psychological, and surgical management strategies.
  • To provide the rationale behind these therapeutic approaches.

Main Methods:

  • Literature review of pediatric constipation management.
  • Analysis of the interaction between physical and psychological elements.
  • Synthesis of evidence for medical, psychological, and surgical interventions.

Main Results:

  • Identified a vicious cycle of pain, fear, retention, and incontinence in pediatric constipation.
  • Highlighted the importance of addressing both physical and psychological components for effective treatment.
  • Summarized various management strategies and their underlying principles.

Conclusions:

  • Effective childhood constipation management necessitates a holistic approach addressing physical and psychological aspects.
  • Understanding the cycle of avoidance and retention is crucial for successful intervention.
  • Integrated medical, psychological, and surgical strategies offer comprehensive care options.

Related Concept Videos

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD: